The tragic poisoning of children in Madhya Pradesh has brought to light the critical safety deficiencies within India’s pharmaceutical industry. As the largest producer of vaccines globally and a major supplier of generic medications, the country faces mounting pressure to overhaul its drug safety protocols. This incident has prompted urgent calls for systemic reforms to prevent similar tragedies in the future.